Literature DB >> 1352381

Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney.

L C Rump1, K Wilde, C Bohmann, P Schollmeyer.   

Abstract

The effects of the classical dopamine DA2-receptor agonist quinpirole (LY 171555) and the recently characterized DA2-receptor agonist, carmoxirole (EMD 45609), on neurotransmission in rat isolated kidney were investigated. After preincubation with 3H-noradrenaline, the renal nerves were electrically stimulated. The stimulation induced (S-I) outflow of radioactivity was taken as an index of noradrenaline release. Quinpirole (0.3 mumol/l) inhibited S-I outflow of radioactivity and pressor-responses to renal nerve stimulation (RNS) at 1 Hz. Both effects of quinpirole were blocked by the DA2-receptor antagonist S(-)-sulpiride (10 mumol/l). The alpha 1, alpha 2-adrenoceptor antagonist phentolamine (1 mumol/l) did not block the inhibitory effect of quinpirole. Carmoxirole (0.003 and 0.03 mumol/l) did not alter and carmoxirole (0.3 mumol/l) even enhanced S-I outflow of radioactivity, however, pressor responses to RNS were markedly reduced by carmoxirole (0.003-0.3 mumol/l). Pressor responses to RNS were also markedly reduced by the alpha 1-adrenoceptor antagonist prazosin (0.1 mumol/l). Carmoxirole (0.3 mumol/l), prazosin (0.1 mumol/l) and phentolamine (1 mumol/l) totally abolished pressor responses to exogenous noradrenaline (0.05 mumol/l). In contrast, quinpirole (0.3 mumol/l) did not alter pressor responses to exogenous noradrenaline (0.05 mumol/l). Furthermore, carmoxirole (0.003-0.3 mumol/l) markedly reduced pressor responses induced by the alpha 1-adrenoceptor agonist methoxamine (1 mumol/l) but even the highest concentration of carmoxirole (0.3 mumol/l) had no effect on pressor responses induced by bolus injections of either neuropeptide Y (1.5 ng) or angiotensin II (1 ng). Phentolamine (1 mumol/l) by itself markedly enhanced S-I outflow of radioactivity and pressor responses to RNS were virtually unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352381     DOI: 10.1007/bf00168691

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Bromocriptine-induced decrease in blood pressure in conscious spontaneously hypertensive rats: evidence for a peripheral site of action.

Authors:  M van den Buuse; A C Lambrechts
Journal:  J Pharm Pharmacol       Date:  1989-09       Impact factor: 3.765

2.  Alpha 2-agonist activity of the dopamine DA2-agonist LY171555.

Authors:  M L Cohen; C J Shaar; W E Colbert
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

3.  Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.

Authors:  A G Dupont; R A Lefebvre; P Vanderniepen
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

Review 4.  Presynaptic alpha-autoreceptors.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1987       Impact factor: 5.545

5.  Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist.

Authors:  A F Haase; H E Greiner; C A Seyfried
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

6.  Renal denervation delays blood pressure increase in the spontaneously hypertensive rat.

Authors:  J F Liard
Journal:  Experientia       Date:  1977-03-15

7.  Prostaglandin E2 inhibits noradrenaline release and purinergic pressor responses to renal nerve stimulation at 1 Hz in isolated kidneys of young spontaneously hypertensive rats.

Authors:  L C Rump; K Wilde; P Schollmeyer
Journal:  J Hypertens       Date:  1990-10       Impact factor: 4.844

8.  Effects of DA-1- and DA-2-dopamine antagonists on apomorphine-induced inhibition of peripheral sympathetic neurotransmission.

Authors:  J Hietala
Journal:  J Auton Pharmacol       Date:  1988-12

Review 9.  Renal nerves in the pathogenesis of hypertension in experimental animals and humans.

Authors:  R E Katholi
Journal:  Am J Physiol       Date:  1983-07

10.  Modulation of norepinephrine release through alpha 1- and alpha 2-adrenoceptors in rat isolated kidney.

Authors:  L C Rump; H Majewski
Journal:  J Cardiovasc Pharmacol       Date:  1987-04       Impact factor: 3.105

View more
  7 in total

1.  Effects of imidazolines on noradrenaline release in rat isolated kidney.

Authors:  C Bohmann; P Schollmeyer; L C Rump
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

2.  Dopamine receptor modulation of noradrenaline release by carmoxirole in human cortical kidney slices.

Authors:  L C Rump; E Schwertfeger; U Schaible; M J Schuster; A Frankenschmidt; P Schollmeyer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Methoxamine inhibits noradrenaline release through activation of alpha 1- and alpha 2-adrenoceptors in rat isolated kidney: involvement of purines and prostaglandins.

Authors:  C Bohmann; P Schollmeyer; L C Rump
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

4.  Alpha 2-autoreceptor subclassification in rat isolated kidney by use of short trains of electrical stimulation.

Authors:  C Bohmann; P Schollmeyer; L C Rump
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

5.  Vasoconstrictor responses to the P2x-purinoceptor agonist beta, gamma-methylene-L-ATP in human cutaneous and renal blood vessels.

Authors:  I von Kügelgen; B Krumme; U Schaible; P J Schollmeyer; L C Rump
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

6.  A study of ATP as a sympathetic cotransmitter in human saphenous vein.

Authors:  L C Rump; I von Kügelgen
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

7.  Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.

Authors:  M Matsumoto; M Yoshioka; H Togashi; T Ikeda; H Saito
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.